Cytactic, a leading cyber crisis management and readiness company, has announced a significant funding round of $16,000,000. With a focus on providing top-notch services to senior management and boards of directors in prominent enterprises and governments worldwide, Cytactic is poised to expand its reach and enhance its offerings. The funding will be instrumental in further developing the company's elite team of experts, who bring unparalleled multidisciplinary experience in managing cyber crisis events. This injection of capital will enable Cytactic to continue delivering premium services and innovative solutions to tackle the ever-evolving challenges of cybersecurity in today's digital landscape.
Cytactic Secures $16 Million in Seed Funding to Revolutionize Cyber Crisis Management Services
Recently funded 路 $16.0M SeedCybersecurity
Get the full Cytactic company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Seed rounds
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | Aisot Technologies Switzerland | Seed | $2.5M | today |
| 2 |  DIMENSION United States | Seed | $1.6M | today |
